Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Disease Progression and HMGCR[original query] |
---|
The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration. Neuroscience letters 2007 Apr 416 (1): 66-70. Porcellini Elisa, Calabrese Elena, Guerini Franca, Govoni Marzia, Chiappelli Martina, Tumini Emanuela, Morgan Kevin, Chappell Sally, Kalsheker Noor, Franceschi Massimo, Licastro Federi |
Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology. Journal of molecular neuroscience : MN 2015 Nov . Leduc Valerie, Théroux Louise, Dea Doris, Dufour Robert, Poirier Jud |
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function. Journal of the American College of Cardiology 2022 8 80 (7): 653-662. Rosoff Daniel B, Bell Andrew S, Jung Jeesun, Wagner Josephin, Mavromatis Lucas A, Lohoff Falk |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: